QuidelOrtho - QDEL Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" QDEL shares.
View QDEL analyst ratings or view top-rated stocks.

5 analysts have issued 12-month price objectives for QuidelOrtho's shares. Their QDEL share price forecasts range from $86.00 to $173.00. On average, they anticipate the company's share price to reach $123.83 in the next year. This suggests a possible upside of 40.6% from the stock's current price.
View analysts price targets for QDEL or view top-rated stocks among Wall Street analysts.

QuidelOrtho's stock was trading at $85.67 at the start of the year. Since then, QDEL stock has increased by 2.8% and is now trading at $88.08.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our QDEL earnings forecast.

QuidelOrtho Co. (NASDAQ:QDEL) posted its earnings results on Thursday, November, 4th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.52 by $1.84. The company earned $509.70 million during the quarter, compared to analyst estimates of $344.25 million. QuidelOrtho had a net margin of 16.80% and a trailing twelve-month return on equity of 20.45%. The company's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.68 EPS.

ETFs with the largest weight of QuidelOrtho (NASDAQ:QDEL) stock in their portfolio include ETFMG Treatments Testing and Advancements ETF (GERM), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Health Care AlphaDEX Fund (FXH), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), SPDR S&P Health Care Equipment ETF (XHE), Pacer US Large Cap Cash Cows Growth Leaders ETF (COWG), ROBO Global Healthcare Technology and Innovation ETF (HTEC) and Ballast Small/Mid Cap ETF (MGMT).

QuidelOrtho issued an update on its FY 2023 earnings guidance on Thursday, February, 16th. The company provided EPS guidance of $5.00-$5.60 for the period, compared to the consensus EPS estimate of $5.19. The company issued revenue guidance of $2.21 billion-$2.25 billion, compared to the consensus revenue estimate of $2.80 billion.

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL."

QuidelOrtho's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (9.85%), ArrowMark Colorado Holdings LLC (4.44%), Senvest Management LLC (4.24%), Fred Alger Management LLC (1.72%), Alyeska Investment Group L.P. (1.63%) and Geode Capital Management LLC (1.28%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends.

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of QDEL stock can currently be purchased for approximately $88.08.

QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $5.86 billion and generates $3.27 billion in revenue each year. The company earns $548.70 million in net income (profit) each year or $12.40 on an earnings per share basis.

The company employs 7,000 workers across the globe.

QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (800) 874-1517, via email at rargueta@quidel.com, or via fax at 858-453-4338.